Nature Communications (Apr 2022)

ACKR3 regulates platelet activation and ischemia-reperfusion tissue injury

  • Anne-Katrin Rohlfing,
  • Kyra Kolb,
  • Manuel Sigle,
  • Melanie Ziegler,
  • Alexander Bild,
  • Patrick Münzer,
  • Jessica Sudmann,
  • Valerie Dicenta,
  • Tobias Harm,
  • Mailin-Christin Manke,
  • Sascha Geue,
  • Marcel Kremser,
  • Madhumita Chatterjee,
  • Chunguang Liang,
  • Hendrik von Eysmondt,
  • Thomas Dandekar,
  • David Heinzmann,
  • Manina Günter,
  • Saskia von Ungern-Sternberg,
  • Manuela Büttcher,
  • Tatsiana Castor,
  • Stine Mencl,
  • Friederike Langhauser,
  • Katharina Sies,
  • Diyaa Ashour,
  • Mustafa Caglar Beker,
  • Michael Lämmerhofer,
  • Stella E. Autenrieth,
  • Tilman E. Schäffer,
  • Stefan Laufer,
  • Paulina Szklanna,
  • Patricia Maguire,
  • Matthias Heikenwalder,
  • Karin Anne Lydia Müller,
  • Dirk M. Hermann,
  • Ertugrul Kilic,
  • Ralf Stumm,
  • Gustavo Ramos,
  • Christoph Kleinschnitz,
  • Oliver Borst,
  • Harald F. Langer,
  • Dominik Rath,
  • Meinrad Gawaz

DOI
https://doi.org/10.1038/s41467-022-29341-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 20

Abstract

Read online

ACKR3 is a critical regulator of platelet-mediated thrombosis and organ injury following ischemia/reperfusion. Platelet ACKR3 surface expression is independently associated with all-cause mortality in patients with cardiovascular diseases.